Dr. Andrew Hemmert is the Senior Vice President of Molecular Research and Development for bioMerieux. Based in Salt Lake City, Andrew leads global teams focused on the creation of easy-to-use, rapid, and comprehensive molecular diagnostics. bioMerieux innovations to infectious disease diagnostics from these teams include the largest available menu for respiratory, blood stream, gastrointestinal, central nervous system, and skeletal infections for hospital customers. Additionally, the bioMerieux SpotFire system, delivers rapid, comprehensive results for the point of care setting. Andrew is also an active contributor to the scientific community through multiple publications, grants, and patents.